Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | +80.85% | +2.56% | +5.30% | +0.24% | +53.64% | +100.96% | +114.42% | +1,003.33% | +261.61% | +283.54% |
| SCBGENOME(E) | +84.73% | +12.70% | +9.85% | +1.47% | +37.00% | +74.81% | +80.34% | +126.38% | −36.51% | −40.54% |
| BCARE | +15.51% | +1.80% | +5.35% | +6.78% | +7.18% | +17.90% | +24.01% | +36.89% | +8.97% | +8.04% |
| TGHDIGI | +7.98% | +4.02% | +6.47% | +5.34% | +12.21% | +19.67% | +5.30% | +38.84% | −41.25% | −40.88% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes NTRA: money market or bond funds, or no holdings data yet
| BCARE | TGHDIGI | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 8.44% | 3.98% |
 AstraZeneca | 3.87% | 3.98% |
 Unitedhealth Group | 2.88% | 4.88% |
 Intuitive Surgical | 2.38% | 3.38% |
 Vertex Pharmaceuticals | 2.28% | 2.69% |
| Only in BCARE | ||
 Merck & | 5.46% | N/A |
 Johnson & Johnson | 4.76% | N/A |
 ABBVIE | 2.48% | N/A |
 GSK | 2.48% | N/A |
| Only in TGHDIGI | ||
 Guardant Health | N/A | 3.48% |
 Natera | N/A | 3.48% |
| Sandoz | N/A | 3.19% |
 Philips | N/A | 2.89% |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(E) | +84.73% | 41.93% | 2.02 |
| NTRA | +80.85% | 51.97% | 1.56 |
| BCARE | +15.51% | 15.99% | 0.97 |
| TGHDIGI | +7.98% | 20.94% | 0.38 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | NTRA | SCBGENOME(E) | BCARE | TGHDIGI |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 44.29 million | 4,742 million | 784 million |
| Inception date | N/A | 20 Aug 2021 | 29 Aug 2007 | 1 Mar 2019 |
| Master fund | N/A | กองทุน ARK Genomic Revolution ETF | Wellington Global Health Care Equity Fund | กองทุน UBS (Lux) Digital Health Equity |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 57.68% | 47.41% | 91.05% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1 THB | 500 THB | 1,000 THB |
| Subsequent purchase | N/A | 1 THB | 500 THB | 1,000 THB |
| Redemption (amount) | N/A | 1 THB | No minimum | No minimum |
| Redemption (units) | N/A | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | 1 THB | No minimum | No minimum |
| Balance (units) | N/A | No minimum | No minimum | 100 units |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+4 | T+5 |
